NASDAQ
Orchard Therapeutics plc (ORTX) has a fcf yield of -174.23% as of Monday, August 3, 2026. This represents a 356.44% decrease compared to its 12-month average of -38.17%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.